Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis

NCT01570504 is registered in ClinicalTrials.gov with Centro per le Malattie Tropicali as lead sponsor.

NCT NCT01570504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01570504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
Lead sponsor
Centro per le Malattie Tropicali
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
June 8, 2018
Enrollment
312 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

strongyloidiasis